Operating revenues, growth data, profitability and the behavior of our products.
Wed, 26/07/2017 - 12:28
0 minOperating revenues, growth data, profitability and the behavior of our products.
Related
ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®
The United States Food and Drug Administration (...
1 min
28/07/2023
ROVI ACHIEVED STABLE TOTAL REVENUE OF 381.0 MILLION EUROS IN THE FIRST POST-PANDEMIC HALF YEAR
Operating revenue remained stable,...
4 min
26/07/2023
ROVI REACHED 201.9 MILLION EUROS OF REVENUE IN THE FIRST POST-PANDEMIC QUARTER
Operating revenue decreased by 2% to 201.6 million...
3 min
10/05/2023
2017 First Half Financial Results.png